Clinical Trial Update: A Phase 1 Study to Compare the PK and Safety of Naproxcinod in Hepatic Impaired Patients and Matching Healthy Subjects [Phase 1]

View source ↗

Summary

Phase 1 study assessing pharmacokinetics and safety of Naproxcinod in hepatic impairment patients versus healthy subjects; the trial is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Disease

Drugs mentioned

• Naproxcinod (naproxcinod)

Snippet

Sponsor: NicOx | Conditions: Liver Disease | Phase 1 | Status: COMPLETED